Blog Posts On Biospecimen Procurement For Industry

02. Ensuring Public Support For Biobank Cooperation With Industry

02. Ensuring Public Support For Biobank Cooperation With Industry

Public Attitudes to Biobank Cooperation With Industry The general finding from studies in North America and Europe is that the level of public trust in, or support for, biobanking research, tends to be lower if industry is involved in either funding or conducting the...

03. The Main Actors Providing Biosamples To Industry

03. The Main Actors Providing Biosamples To Industry

Most human biosamples originate in the public sector, for example in public hospitals and publicly-funded population biobanks. So some kind of public-private partnership is generally needed for biosamples to reach researchers in the private (industry) sector. Human...

04. Biosample Needs of Different Industry Players

04. Biosample Needs of Different Industry Players

This article examines three different actors in industry that require biosamples including: Large pharmaceutical companies Large in vitro diagnostics companies Small and medium enterprises (SMEs) in healthcare biotechnology The article describes the major differences...

05. The Dual Role of Academic Biobanks

05. The Dual Role of Academic Biobanks

Academic biobanks support research by providing human biospecimen access. They have a dual role: they need to support two actors in a production that leads to new drugs and diagnostics with resulting advances in patient care. The two actors they need to support are...

06. What is Commodification?

06. What is Commodification?

What is commodification? According to one dictionary definition it is 'the action or process of treating something as a mere commodity'. A commodity is 'a substance or product that can be traded, bought, or sold'. Commodification is a word generally used in a...

07. Acceptable Transactions in Biobanking

07. Acceptable Transactions in Biobanking

One of the multiple factors that inhibits the supply of human biological samples from academic biobanks to researchers in industry, is concern about legal issues. There is uncertainty about what is and is not legitimate in terms of financial transactions. As noted by...

08. Why Biobank Access Policies Should Be Publicly Available

08. Why Biobank Access Policies Should Be Publicly Available

The process of finding a suitable academic biobank is not easy for industry researchers. Not only must the biobank have the biosamples required, but also it must have policies that allow industry access. Biobank access policies may contain exclusion criteria that...

09. Biospecimen Provenance: What Researchers Need To Know

09. Biospecimen Provenance: What Researchers Need To Know

Every biosample or tissue sample used for medical research has a different journey. The journey starts when the tissue sample is donated by a person. The journey should ideally involve processing and storage by a professional biorepository. The journey ends when the...